A shed form of LDL receptor-related protein-1 regulates peripheral nerve injury and neuropathic pain in rodents

Journal of Clinical Investigation

Volumn 118, Issue 1, 2008, Pages 161-172

  Gaultier, Alban ^a   Arandjelovic, Sanja ^a   Li, Xiaoqing ^b   Janes, Julie ^b   Dragojlovic, Nikola ^a   Zhou, George P ^b   Dolkas, Jenny ^b   Myers, Robert R ^a,b   Gonias, Steven L ^a   Campana, W Marie ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ALPHA CHAIN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GLIA CELL; IN VITRO STUDY; MICROGLIA; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RAT; REGULATORY MECHANISM; SCHWANN CELL; SCIATIC NERVE; SPINAL CORD DORSAL HORN;

ANIMALS; ASTROCYTES; CELLS, CULTURED; CHRONIC DISEASE; CONSTRICTION; ENDOCYTOSIS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; LDL-RECEPTOR RELATED PROTEIN 1; LIGANDS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICROGLIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PAIN; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY; SCHWANN CELLS; SCIATIC NERVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38149087650     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32371     Document Type: Article

References (80)

1. Herz, J., and Strickland, D.K. 2001. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108:779-784.
2. Houston, D.W., and Wylie, C. 2002. Cloning and expression of Xenopus Lrp5 and Lrp6 genes. Mech. Dev. 117:337-342.
3. Wehrli, M., et al. 2000. Arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature. 407:527-530.
4. Yochem, J., and Greenwald, I. 1993. A gene for a low density lipoprotein receptor-related protein in the nematode Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 90:4572-4576.
5. Pinson, K.I., Brennan, J., Monkley, S., Avery, B.J., and Skarnes, W.C. 2000. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature. 407:535-538.
6. Trommsdorff, M., et al. 1999. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell. 97:689-701.
7. Boucher, P., Gotthardt, M., Li, W.P., Anderson, R.G., and Herz, J. 2003. LRP: role in vascular wall integrity and protection from atherosclerosis. Science. 300:329-332.
8. Li, Y., Lu, W., He, X., Schwartz, A.L., and Bu, G. 2004. LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution. Oncogene. 23:9129-9135.
9. Zerbinatti, C.V., and Bu, G. 2005. LRP and Alzheimer's disease. Rev. Neurosci. 16:123-135.
10. Willnow, T.E., Moehring, J.M., Inocencio, N.M., Moehring, T.J., and Herz, J. 1996. The low-density-lipoprotein receptor-related protein (LRP) is processed by furin in vivo and in vitro. Biochem. J. 313:71-76.
11. Strickland, D.K., Gonias, S.L., and Argraves, W.S. 2002. Diverse roles for the LDL receptor family. Trends Endocrinol. Metab. 13:66-74.
12. Gotthardt, M., et al. 2000. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J. Biol. Chem. 275:25616-25624.
13. Kinoshita, A., et al. 2001. Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65. J. Neurosci. 21:8354-8361.
14. Su, H.P., et al. 2002. Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J. Biol. Chem. 277:11772-11779.
15. Gonias, S.L., Wu, L., and Salicioni, A.M. 2004. Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome. Thromb. Haemost. 91:1056-1064.
16. Gaultier, A., Salicioni, A.M., Arandjelovic, S., and Gonias, S.L. 2006. Regulation of the composition of the extracellular matrix by low density lipoprotein receptor-related protein-1. J. Biol. Chem. 281:7332-7340.
17. Polavarapu, R., et al. 2007. Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood. 109:3270-3278.
18. Yepes, M., et al. 2003. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 112:1533-1540.
19. Shibata, M., et al. 2000. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106:1489-1499.
20. Campana, W.M., et al. 2006. The low-density lipoprotein receptor-related protein is a pro-survival receptor in Schwann cells: possible implications in peripheral nerve injury. J. Neurosci. 26:11197-11207.
21. Rozanov, D.V., Hahn-Dantona, E., Strickland, D.K., and Strongin, A.Y. 2004. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells. J. Biol. Chem. 279:4260-4268.
22. May, P., Reddy, Y.K., and Herz, J. 2002. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277:18736-18743.
23. von Arnim, C.A., et al. 2005. The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J. Biol. Chem. 280:17777-17785.
24. Hu, X., et al. 2006. Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9:1520-1525.
25. Quinn, K.A., et al. 1997. Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. J. Biol. Chem. 272:23946-23951.
26. Shamash, S., Reichert, F., and Rotshenker, S. 2002. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 22:3052-3060.
27. Stoll, G., Jander, S., and Myers, R.R. 2002. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J. Peripher. Nerv. Syst. 7:13-27.
28. Myers, R.R., Campana, W.M., and Shubayev, V.I. 2006. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov. Today. 11:8-20.
29. Hashizume, H., DeLeo, J.A., Colburn, R.W., and Weinstein, J.N. 2000. Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine. 25:1206-1217.
30. Takahashi, N., Kikuchi, S., Shubayev, V.I., Campana, W.M., and Myers, R.R. 2006. TNF-alpha and phosphorylation of ERK in DRG and spinal cord: insights into mechanisms of sciatica. Spine. 31:523-529.
31. Jin, X., and Gereau, R.W. 2006. Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J. Neurosci. 26:246-255.
32. Schafers, M., Brinkhoff, J., Neukirchen, S., Marziniak, M., and Sommer, C. 2001. Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice. Neurosci. Lett. 310:113-116.
33. Sorkin, L.S., Xiao, W.H., Wagner, R., and Myers, R.R. 1997. Tumour necrosis factor-alpha induces ectopic activity in noceiceptive primary afferent fibres. Neuroscience. 81:255-262.
34. Wagner, R., Myers, R.R., and O'Brien, J.S. 1998. Prosaptide prevents hyperalgesia and reduces peripheral TNFR1 expression following TNF-alpha nerve injection. Neuroreport. 9:2827-2831.
35. Wagner, R., and Myers, R.R. 1996. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport. 7:2897-2901.
36. Bennett, G.J., and Xie, Y.K. 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:87-107.
37. Wu, L., Arandjelovic, S., and Gonias, S.L. 2004. Effects of low density lipoprotein receptor-related protein-1 on the expression of platelet-derived growth factor beta-receptor in vitro. J. Cell Biochem. 93:1169-1177.
38. Medh, J.D., et al. 1995. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J. Biol. Chem. 270:536-540.
39. Williams, S.E., Ashcom, J.D., Argraves, W.S., and Strickland, D.K. 1992. A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. J. Biol. Chem. 267:9035-9040.
40. Quinn, K.A., Pye, V.J., Dai, Y.P., Chesterman, C.N., and Owensby, D.A. 1999. Characterization of the soluble form of the low density lipoprotein receptor-related protein (LRP). Exp. Cell Res. 251:433-441.
41. Myers, R.R., et al. 2003. Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp. Neurol. 184:606-614.
42. Chandross, K.J., et al. 1996. TNF alpha inhibits Schwann cell proliferation, connexin46 expression, and gap junctional communication. Mol. Cell. Neurosci. 7:479-500.
43. Campana, W.M., Hiraiwa, M., and O'Brien, J.S. 1998. Prosaptide activates the MAPK pathway by a G-protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells. FASEB J. 12:307-314.
44. Jessen, K.R., Morgan, L., Stewart, H.J., and Mirsky, R. 1990. Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: development and regulation by neuron-Schwann cell interactions. Development. 109:91-103.
45. Wajant, H., Pfizenmaier, K., and Scheurich, P. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10:45-65.
46. Baldassare, J.J., Bi, Y., and Bellone, C.J. 1999. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J. Immunol. 162:5367-5373.
47. Thirunavukkarasu, C., Watkins, S.C., and Gandhi, C.R. 2006. Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK. Hepatology. 44:389-398.
48. Asbury, A.K., and Johnson, P.C. 1978. Pathology of peripheral nerve. Major Probl. Pathol. 9:1-311.
49. Kleinschnitz, C., Brinkhoff, J., Zelenka, M., Sommer, C., and Stoll, G. 2004. The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J. Neuroimmunol. 149:77-83.
50. Skundric, D.S., Bealmear, B., and Lisak, R.P. 1997. Induced upregulation of IL-1, IL-1RA and IL-1R type I gene expression by Schwann cells. J. Neuroimmunol. 74:9-18.
51. Campana, W.M., et al. 2006. Erythropoietin reduces Schwann cell TNF-alpha, Wallerian degeneration and pain-related behaviors after peripheral nerve injury. Eur. J. Neurosci. 23:617-626.
52. Netea, M.G., et al. 1996. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J. Clin. Invest. 97:1366-1372.
53. Raghavendra, V., Tanga, F.Y., and DeLeo, J.A. 2004. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur. J. Neurosci. 20:467-473.
54. Schafers, M., Svensson, C.I., Sommer, C., and Sorkin, L.S. 2003. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 23:2517-2521.
55. Raghavendra, V., Rutkowski, M.D., and DeLeo, J.A. 2002. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J. Neurosci. 22:9980-9989.
56. Milligan, E.D., et al. 2003. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci. 23:1026-1040.
57. Ma, W., and Quirion, R. 2005. The ERK/MAPK pathway, as a target for the treatment of neuropathic pain. Expert Opin. Ther. Targets. 9:699-713.
58. Svensson, C.I., et al. 2003. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J. Neurochem. 86:1534-1544.
59. Grimsley, P.G., Quinn, K.A., Chesterman, C.N., and Owensby, D.A. 1999. Evolutionary conservation of circulating soluble low density lipoprotein receptor-related protein-like ("LRP-like") molecules. Thromb. Res. 94:153-164.
60. Kounnas, M.Z., Church, F.C., Argraves, W.S., and Strickland, D.K. 1996. Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and alpha 1-antitrypsintrypsin complexes is mediated by the low density lipoprotein receptor-related protein. J. Biol. Chem. 271:6523-6529.
61. Fischer, D.G., Tal, N., Novick, D., Barak, S., and Rubinstein, M. 1993. An antiviral soluble form of the LDL receptor induced by interferon. Science. 262:250-253.
62. Guo, Y., et al. 2007. Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells. J. Orthop. Res. 25:964-971.
63. Sagare, A., et al. 2007. Clearance of amyloid-beta by circulating lipoprotein receptors. Nat. Med. 13:1029-1031.
64. Wilsie, L.C., and Orlando, R.A. 2003. The low density lipoprotein receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism. J. Biol. Chem. 278:15758-15764.
65. Beutler, B. 2002. TLR4 as the mammalian endotoxin sensor. Curr. Top. Microbiol. Immunol. 270:109-120.
66. Jo, M., Thomas, K.S., Wu, L., and Gonias, S.L. 2003. Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling. J. Biol. Chem. 278:46692-46698.
67. Grimsley, P.G., Quinn, K.A., and Owensby, D.A. 1998. Soluble low-density lipoprotein receptor-related protein. Trends Cardiovasc. Med. 8:363-368.
68. Hayashi, H., Campenot, R.B., Vance, D.E., and Vance, J.E. 2007. Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1. J. Neurosci. 27:1933-1941.
69. Macdonald, R., Bingham, S., Bond, B.C., Parsons, A.A., and Philpott, K.L. 2001. Determination of changes in mRNA expression in a rat model of neuropathic pain by Taqman quantitative RT-PCR. Brain Res. Mol. Brain Res. 90:48-56.
70. Campana, W.M., et al. 2006. Erythropoietin reduces Schwann cell TNF-α, Wallerian degeneration and pain- related behaviors after peripheral nerve injury. Eur. J. Neurosci. 23:617-626.
71. Ranganathan, S., et al. 2004. Serine and threonine phosphorylation of the low density lipoprotein receptor-related protein by protein kinase Calpha regulates endocytosis and association with adaptor molecules. J. Biol. Chem. 279:40536-40544.
72. Herz, J., Goldstein, J.L., Strickland, D.K., Ho, Y.K., and Brown, M.S. 1991. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J. Biol. Chem. 266:21232-21238.
73. Hiraiwa, M., Taylor, E., Campana, W.M., Darin S.J., and O'Brien, J.S. 1997. Cell death prevention, mitogen-activated protein kinase stimulation and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc. Natl. Acad. Sci. U. S. A. 94:4778-4781.
74. Liu, B., et al. 2001. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J. Neurochem. 77:182-189.
75. Campana, W.M., Darin, S.J., and O'Brien, J.S. 1999. Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells. J. Neurosci. Res. 57:332-341.
76. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
77. Campana, W.M., and Myers, R.R. 2001. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. FASEB J. 15:1804-1806.
78. Livak, K.J., and Schmittgen, T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402-408.
79. Pfaffl, M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
80. Chattopadhyay, S., Myers, R.R., Janes, J., and Shubayev, V. 2007. Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve. Brain Behav. Immun. 21:561-568.